background image

Paid Clinical Trials Annapolis

Discover 2,405 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Gleolan

Recruiting
PHASE3

Sponsor:

NX Development Corp

Location:

Annapolis MD

Code:

NCT05804370

Conditions

Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gleolan

dTMS & CBT

Recruiting

Sponsor:

Brainsway

Location:

Annapolis MD, Glen Burnie MD, Greenbelt MD, Columbia MDshow 17 more

Code:

NCT04455646

Conditions

Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment

Eligibility Criteria

Sex: All

Age: 22 - 68

Healthy Volunteers: Not accepted

Interventions

CBT-based, mobile-delivered, intervention platform

Selinexor & Ruxolitinib

Recruiting
PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Annapolis MD, Baltimore MD, Columbia MD, Brandywine MDshow 30 more

Code:

NCT04562389

Conditions

Myelofibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Placebo

Ruxolitinib

Ovarian Cancer Test

Recruiting

Sponsor:

Massachusetts General Hospital

Location:

Annapolis MD, Baltimore MD, Little Rock AR, Seattle WA

Code:

NCT04794322

Conditions

Ovarian Neoplasms

Ovarian Epithelial Carcinoma

Fallopian Tube Neoplasms

High Grade Ovarian Serous Adenocarcinoma

Stage I Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 30+

Healthy Volunteers: Not accepted

Interventions

Uterine lavage, or a wash of the womb

Blood sample

Pap smear

Mezigdomide & Carfilzomib

Recruiting
PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Annapolis MD, Norfolk VA, Little Silver NJ, Bronx NYshow 28 more

Code:

NCT05552976

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Mezigdomide

Carfilzomib

Dexamethasone

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Lanifibranor

Recruiting
PHASE3

Sponsor:

Inventiva Pharma

Location:

Annapolis MD, Greenbelt MD, Baltimore MD, Columbia MDshow 151 more

Code:

NCT04849728

Conditions

NASH - Nonalcoholic Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IVA337

Placebo

Observational Study

Recruiting

Sponsor:

Ensoma

Location:

Annapolis MD, Washington DC, Dover DE, Harrisburg PAshow 46 more

Code:

NCT06605378

Conditions

Chronic Granulomatous Disease (CGD)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

CHF6001 with Roflumilast

Recruiting
PHASE3

Sponsor:

Chiesi Farmaceutici S.p.A.

Location:

Annapolis MD, Baltimore MD, Philadelphia PA, Bayonne NJshow 84 more

Code:

NCT04636814

Conditions

Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

CHF6001 1600Γö¼Γòíg

CHF6001 3200Γö¼Γòíg

Placebo

Roflumilast

Zanubrutinib & Anti-CD20

Recruiting
PHASE3

Sponsor:

BeiGene

Location:

Annapolis MD, Baltimore MD, Bethesda MD, York PAshow 56 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab

PF-07220060 with Letrozole

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Annapolis MD, Baltimore MD, Washington D.C. DC, Torontoshow 39 more

Code:

NCT06760637

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07220060

letrozole

abemaciclib

palbociclib

ribociclib